Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283762011> ?p ?o ?g. }
- W4283762011 endingPage "3115" @default.
- W4283762011 startingPage "3102" @default.
- W4283762011 abstract "Abstract Accumulating evidence has demonstrated that drug resistance can be acquired in cancer through the repopulation of tumors by cancer stem cell (CSC) expansion. Here, we investigated mechanisms driving resistance and CSC repopulation in hepatocellular carcinoma (HCC) as a cancer model using two drug-resistant, patient-derived tumor xenografts that mimicked the development of acquired resistance to sorafenib or lenvatinib treatment observed in patients with HCC. RNA sequencing analysis revealed that cholesterol biosynthesis was most commonly enriched in the drug-resistant xenografts. Comparison of the genetic profiles of CD133+ stem cells and CD133− bulk cells from liver regeneration and HCC mouse models showed that the cholesterol pathway was preferentially upregulated in liver CSCs compared with normal liver stem cells. Consistently, SREBP2-mediated cholesterol biosynthesis was crucial for the augmentation of liver CSCs, and loss of SREBP2 conferred sensitivity to tyrosine kinase inhibitors, suggesting a role in regulation of acquired drug resistance in HCC. Similarly, exogenous cholesterol-treated HCC cells showed enhanced cancer stemness abilities and drug resistance. Mechanistically, caspase-3 (CASP3) mediated cleavage of SREBP2 from the endoplasmic reticulum to promote cholesterol biosynthesis, which consequently caused resistance to sorafenib/lenvatinib treatment by driving activation of the sonic hedgehog signaling pathway. Simvastatin, an FDA-approved cholesterol-lowering drug, not only suppressed HCC tumor growth but also sensitized HCC cells to sorafenib. These findings demonstrate that CSC populations in HCC expand via CASP3-dependent, SREBP2-mediated cholesterol biosynthesis in response to tyrosine kinase inhibitor therapy and that targeting cholesterol biosynthesis can overcome acquired drug resistance. Significance: This study finds that cholesterol biosynthesis supports the expansion of cancer stem cell populations to drive resistance to tyrosine kinase inhibitor therapy in hepatocellular carcinoma, identifying potential therapeutic approaches for improving cancer treatment." @default.
- W4283762011 created "2022-07-02" @default.
- W4283762011 creator A5002294653 @default.
- W4283762011 creator A5007204095 @default.
- W4283762011 creator A5007585753 @default.
- W4283762011 creator A5011322415 @default.
- W4283762011 creator A5013430782 @default.
- W4283762011 creator A5028539656 @default.
- W4283762011 creator A5030018828 @default.
- W4283762011 creator A5033018981 @default.
- W4283762011 creator A5034611795 @default.
- W4283762011 creator A5036574094 @default.
- W4283762011 creator A5042809761 @default.
- W4283762011 creator A5045469075 @default.
- W4283762011 creator A5046830245 @default.
- W4283762011 creator A5048914063 @default.
- W4283762011 creator A5058229542 @default.
- W4283762011 creator A5072969391 @default.
- W4283762011 creator A5073155409 @default.
- W4283762011 creator A5081799279 @default.
- W4283762011 creator A5087400947 @default.
- W4283762011 creator A5091697161 @default.
- W4283762011 date "2022-06-29" @default.
- W4283762011 modified "2023-10-10" @default.
- W4283762011 title "Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma" @default.
- W4283762011 cites W1724078287 @default.
- W4283762011 cites W1875555978 @default.
- W4283762011 cites W1982385780 @default.
- W4283762011 cites W1994193851 @default.
- W4283762011 cites W2002072152 @default.
- W4283762011 cites W2010653264 @default.
- W4283762011 cites W2015708085 @default.
- W4283762011 cites W2068424305 @default.
- W4283762011 cites W2083701433 @default.
- W4283762011 cites W2090689798 @default.
- W4283762011 cites W2107948640 @default.
- W4283762011 cites W2141336152 @default.
- W4283762011 cites W2141369960 @default.
- W4283762011 cites W2153935627 @default.
- W4283762011 cites W2158362968 @default.
- W4283762011 cites W2159313433 @default.
- W4283762011 cites W2315305467 @default.
- W4283762011 cites W2509291718 @default.
- W4283762011 cites W2539886351 @default.
- W4283762011 cites W2582729774 @default.
- W4283762011 cites W2592717780 @default.
- W4283762011 cites W2620610745 @default.
- W4283762011 cites W2784611114 @default.
- W4283762011 cites W2787358630 @default.
- W4283762011 cites W2790874655 @default.
- W4283762011 cites W2800738234 @default.
- W4283762011 cites W2808027013 @default.
- W4283762011 cites W2897217795 @default.
- W4283762011 cites W2897934013 @default.
- W4283762011 cites W2905891236 @default.
- W4283762011 cites W2925521234 @default.
- W4283762011 cites W2945133689 @default.
- W4283762011 cites W2972619269 @default.
- W4283762011 cites W3013551968 @default.
- W4283762011 cites W3103828236 @default.
- W4283762011 cites W3157452721 @default.
- W4283762011 cites W3180684760 @default.
- W4283762011 cites W3188334818 @default.
- W4283762011 cites W3190664082 @default.
- W4283762011 cites W3202642825 @default.
- W4283762011 cites W3208877024 @default.
- W4283762011 cites W4205655334 @default.
- W4283762011 doi "https://doi.org/10.1158/0008-5472.can-21-2934" @default.
- W4283762011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35767704" @default.
- W4283762011 hasPublicationYear "2022" @default.
- W4283762011 type Work @default.
- W4283762011 citedByCount "12" @default.
- W4283762011 countsByYear W42837620112023 @default.
- W4283762011 crossrefType "journal-article" @default.
- W4283762011 hasAuthorship W4283762011A5002294653 @default.
- W4283762011 hasAuthorship W4283762011A5007204095 @default.
- W4283762011 hasAuthorship W4283762011A5007585753 @default.
- W4283762011 hasAuthorship W4283762011A5011322415 @default.
- W4283762011 hasAuthorship W4283762011A5013430782 @default.
- W4283762011 hasAuthorship W4283762011A5028539656 @default.
- W4283762011 hasAuthorship W4283762011A5030018828 @default.
- W4283762011 hasAuthorship W4283762011A5033018981 @default.
- W4283762011 hasAuthorship W4283762011A5034611795 @default.
- W4283762011 hasAuthorship W4283762011A5036574094 @default.
- W4283762011 hasAuthorship W4283762011A5042809761 @default.
- W4283762011 hasAuthorship W4283762011A5045469075 @default.
- W4283762011 hasAuthorship W4283762011A5046830245 @default.
- W4283762011 hasAuthorship W4283762011A5048914063 @default.
- W4283762011 hasAuthorship W4283762011A5058229542 @default.
- W4283762011 hasAuthorship W4283762011A5072969391 @default.
- W4283762011 hasAuthorship W4283762011A5073155409 @default.
- W4283762011 hasAuthorship W4283762011A5081799279 @default.
- W4283762011 hasAuthorship W4283762011A5087400947 @default.
- W4283762011 hasAuthorship W4283762011A5091697161 @default.
- W4283762011 hasBestOaLocation W42837620112 @default.
- W4283762011 hasConcept C121608353 @default.
- W4283762011 hasConcept C126322002 @default.
- W4283762011 hasConcept C2776231280 @default.